Yersinia pestis (plague) vaccines

Bibliography

• DUPLAIX N: Fleas - the lethal leapers. National Geographic (1988) 173:672–694.
   Google Scholar
• PERRY RD, FETHERSTON JD: Yersinia pestis - etiologic agent of plague. Clin. Microbia Rev (1997) 10:35–66.
   PubMed Web of Science ®Google Scholar
• ••This reference provides an excellent overview of the biology of Y pestis.
   Google Scholar
• INGLESBY TV, DENNIS DT, HENDERSON DA et al: Plague as a biological weapon - medical and public health management. JAMA (2000) 283:2281–2290.
   PubMed Web of Science ®Google Scholar
• ANON: Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. (1996) 45:1–15.
   PubMedGoogle Scholar
• ANON: Human Plague in 1998 and 1999. World Health Organ. Wkly Epidemia Rec. (2000) 75:337–344.
   PubMedGoogle Scholar
• FRITZ CL, DENNIS DT, TIPPLE MA et al.: Surveillance for pneumonic plague in the United States during an international emergency: a model for control of imported emerging disease. Emerg. Infect. Dis. (1996) 2:30–36.
   PubMed Web of Science ®Google Scholar
• DAVEY S: Removing Obstacles to Healthy Development. Leotsakos A (Ed.), World Health Organization, Switzerland (1999).
   Google Scholar
• AUTHORS NOT LISTED: Health Aspects of Chemical and Biological Weapons (Pt Edition). World Health Organisation, Geneva (1970).
   Google Scholar
• •This reference provides an overview of the use of Y pestisas a biological weapon.
   Google Scholar
• BRUBAKER RR: Factors promoting acute and chronic diseases caused by yersiniae. Clin. Microbia Rev (1991) 4:309–324.
   PubMed Web of Science ®Google Scholar
• ••This reference provides a review ofvirulence mechanisms of Yersinia.
   Google Scholar
• CAVANAUGH DC: Specific effect of temperature upon transmission of the plague bacillus by the oriental rat flea Xenopsylla cheopis. Am. J. Trop. Med. Hyg. (1971) 20:264–272.
   PubMed Web of Science ®Google Scholar
• DU YD, ROSQVIST R, FORSBERG A: Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. (2002) 70:1453–1460.
   PubMed Web of Science ®Google Scholar
• CAVANAUGH DC, RANDALL R: The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. J. Immuna (1959) 83:348–363.
   PubMed Web of Science ®Google Scholar
• OYSTON PCF, DORRELL N, WILLIAMS K et al.: The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect. Immun. (2000) 68:3419–3425.
   PubMed Web of Science ®Google Scholar
• WILLIAMS RC, GEWURZ H, QUIE PG: Effects of fraction 1 from Yersinia pestis on phagocytosis M vitro. J. Infect. Dis. (1972) 126:235–241.
   PubMed Web of Science ®Google Scholar
• POLAND JD, BARNES AM: Plague. In: CRC Handbook Series in Zoonoses. Section A. Bacteria], Rickettsia], and Mycotic Diseases. Steele JH (Ed.), CRC Press, Boca Raton, FL, USA (1979):515–597.
   Google Scholar
• MEYER KF: Pneumonic plague. Bacteria Rev (1961) 35:249–261.
   Google Scholar
• CHRISTIE AB, CORBEL MJ: Plague and other yersinial diseases. In: Topley, and WilsonS Principles of Bacteriology Virology and Immuni0i. Smith GR (Ed), Edward Arnold, London, UK (1990):399–410.
   Google Scholar
• TITBALL RW, ELEY S, WILLIAMSON ED, DENNIS DT: Plague. In: Vaccines. Plotkin SA, Orenstein WA, Zorab R (Eds), WB Saunders Company, Philadelphia, USA (1999):734–742.
   Google Scholar
• ••This reference provides an up-to-dateand detailed review of existing plague vaccines and summarises approaches to new vaccines.
   Google Scholar
• MEYER KF, FOSTER LE: Measurement ofprotective serum antibodies in human volunteers inoculated with plague prophylactics. Stanford Med. Bull. (1948) 6:75–79.
   PubMedGoogle Scholar
• BARTELLONI PJ, MARSHALL JD, CAVANAUGH DC: Clinical and serological responses to plague vaccine. Mil Med. (1973) 138:720–722.
   PubMed Web of Science ®Google Scholar
• MEYER KF: Effectiveness of live of killed plague vaccines in man. Bull. World Health Organ. (1970) 42:653–666.
   PubMed Web of Science ®Google Scholar
• VON METZ E, EISLER DM, HOTTLE GA: Immunogenicity of plague vaccines in mice and guinea pigs. Appl. Microbia (1971) 22:84–88.
   PubMedGoogle Scholar
• MEYER KF, SMITH G, FOSTER LE, MARSHALL JD, CAVANAUGH DC: Plague immunization. IV. Clinical reactions and serologic response to inoculations of Haffekine and freeze-dried plague vaccine. J. Infect. Dis. (1974) 129:S30–S36.
   Google Scholar
• BRUBAKER RR: Mutation rate to non-pigmentation in Pasturella pestis. Bacteria (1969) 98:1404–1406.
   PubMed Web of Science ®Google Scholar
• RUSSELL P, ELEY SM, HIBBS SE et al: A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine (1995) 13:1551–1556.
   PubMed Web of Science ®Google Scholar
• MEYER KF, CAVANAUGH DC, BARTELLONI PJ, MARSHALL JD: Plague immunization. I. Past and present trends. J. Infect. Dis. (1974) 129:S13–S18.
   Google Scholar
• NAUMOV AV, LED VANOV MY, DROZDOV IG: Plague immunology Russian Research Anti-Plague Institute 'Microbe', Saratov, Russia (1992).
   Google Scholar
• WILLIAMS JE, ALTIERI PL, BERMAN S, LOWENTHAL JP, CAVANAUGH DC: Potency of killed plague vaccines prepared from avirulent Yersinia pestis. Bull. World Health. Organ. (1980) 58:753–756.
   PubMed Web of Science ®Google Scholar
• REISMAN RE: Allergic reactions due to plague vaccine. Allergy (1970) 46:49–56.
   Web of Science ®Google Scholar
• MARSHALL JDJ, BARTELLONI PJ, CAVANAUGH DC, KADULL PJ, MEYER KF: Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine. J. Infect. Dis. (1974) 129:S19–S25.
   Google Scholar
• WILLIAMS JE, CAVANAUGH DC: Measuring the efficacy of vaccination in affording protection against plague. Bull. World Health Organ. (1979) 57:309–313.
   PubMed Web of Science ®Google Scholar
• CAVANAUGH DC, ELISBERG BL, LLEWLLYN CH et al.: Plague immunisation. V. Indirect evidence for the efficacy of plague vaccine. J. Infect. Dis. (1974) 129:S37–S40.
   Google Scholar
• BARNES AM: Surveillance and control ofbubonic plague in the United States. Symp. Zoo] Soc. Lond (1982) 50:237–270.
   Google Scholar
• COHEN RJ, STOCKARD JL: Pneumonic plague in an untreated plague vaccinated individual. JAMA (1967) 202:365–366.
   PubMed Web of Science ®Google Scholar
• FRIEDLANDER AM, WELKOS SL, WORSHAM PL et al.: Relationship between virulence and immunity as revealed in recent studies of the Fl capsule of Yersinia pestis Clin. Infect. Dis. (1995) 21:S178–S181.
   Google Scholar
• HOHMANN EL, OLETTA CA, KILLEEN KP, MILLER SI: phoP/phoQ-deleted Salmonella opin (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis. (1996) 173:1408–1414.
   PubMed Web of Science ®Google Scholar
• DOUGAN G: The molecular-basis for thevirulence of bacterial pathogens - implications for oral vaccine development. Microbiology (UK) (1994) 140:215–224.
   PubMed Web of Science ®Google Scholar
• OCALLAGHAN D, MASKELL D, LIEW FY, EASMON CSF, DOUGAN G: Characterization of aromatic-dependent and purine-dependent Salmonella typhimurium- attenuation, persistence, and ability to induce protective immunity in Balb/C mice. Infect. Inman. (1988) 56:419–423.
   PubMed Web of Science ®Google Scholar
• SMITH BP, REINAGUERRA M, HOISETH SK et al.: Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. Am. J. Vet. Res. (1984) 45:59–66.
   PubMed Web of Science ®Google Scholar
• OYSTON PCF, RUSSELL P, WILLIAMSON ED, TITBALL RW: An aroA mutant of Yersinia pestisis attenuated in guinea-pigs, but virulent in mice. Microbiology(1996) 142:1847–1853.
   PubMed Web of Science ®Google Scholar
• WILLIAMS K, OYSTON PCF, DORRELL N et al.: Investigation into the role of the serine protease HtrA in Yersinia pestis pathogenesis. FEMS Microbiol Lett. (2000) 186:281–286.
   PubMed Web of Science ®Google Scholar
• FLASHNER Y, MAMROUD E, TIDHAR A et al.: Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates. Infect. Inman. (2004) 72:908–915.
   PubMed Web of Science ®Google Scholar
• •This reference describes a recently isolated attenuated mutant of Y pestis that could be exploited as a live vaccine against plague.
   Google Scholar
• WILLIAMSON ED, ELEY SM, GRIFFIN KF et al.: A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med. Microbiol (1995) 12:223–230.
   PubMedGoogle Scholar
• •This reference details the protection afforded by an Fl- and V-antigen subunit vaccine.
   Google Scholar
• LEARY SEC, WILLIAMSON ED, GRIFFIN KF et al.: Active immunisation with V-antigen from Yersinia pestis protects against plague. Infect. Immun. (1995) 63:2854–2858.
   PubMed Web of Science ®Google Scholar
• ANDREWS GP, HEATH DG, ANDERSON GWJ, WELKOS SL, FRIEDLANDER AM: Fraction 1 capsular antigen (F1) purification from Yersinia pestis C092 and from an Escherichia cob recombinant strain and efficacy against lethal challenge. Infect. Immun. (1996) 64:2180–2187.
   PubMed Web of Science ®Google Scholar
• MOTIN VL, NAKAJIMA R, SMIRNOV GB, BRUBAKER RR: Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V fusion peptide. Infect. Immun. (1994) 62:4192–4201.
   PubMed Web of Science ®Google Scholar
• MOTIN VL, NEDIALKOV YA, BRUBAKER RR: V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague. Infect. Immun. (1996) 64:4313–4318.
   PubMed Web of Science ®Google Scholar
• UNE T, BRUBAKER RR: Roles of V antigen in promoting virulence and immunity in yersinia. Immunol (1984) 133:2226–2230.
   Web of Science ®Google Scholar
• ROGGENKAMP A, GEIGER AM, LEITRITZ L, KESSLER A, HEESEMANN J: Passive immunity to infection with Yersinia spp mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect. Inman. (1997) 65:446–451.
   PubMed Web of Science ®Google Scholar
• TITBALL RW, HOWELLS AM, OYSTON PCF, WILLIAMSON ED: Expression of the Yersinia pestis capsular antigen (Fl-antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague. Infect. Inman. (1997) 65:1926–1930.
   PubMed Web of Science ®Google Scholar
• HEATH DG, ANDERSON GWJ, MAURO JM et al.: Protection against experimental bubonic and pneumonic plague by a recombinant capsular Fl-V antigen fusion protein vaccine. Vaccine (1998) 16:1131–1137.
   PubMed Web of Science ®Google Scholar
• ANDERSON GWJ, HEATH DG, BOLT CR, WELKOS SL, FRIEDLANDER AM: Short- and long-term efficacy of single dose subunit vaccines against Yersinia pestisin mice. Am. J. Trop. Med. Hyg. (1998) 58:793–799.
   PubMed Web of Science ®Google Scholar
• WILLIAMSON ED, VESEY PM, GILLHESPY KJ et al.: An IgG1 titre to the Fl and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol (1999) 116:107–114.
   PubMed Web of Science ®Google Scholar
• ZAVIALOV AV, BERGLUND J, PUDNEY AF et al.: Structure and biogenesis of the capsular Fl antigen from Yersinia pestis: preserved folding energy drives fiber formation. Cell (2003) 113:587–596.
   PubMed Web of Science ®Google Scholar
• MILLER J, WILLIAMSON ED, LAKEY JH et al.: Macromolecular organisation of recombinant Yersinia pestis Fl antigen and the effect of structure on immunogenicity. FEMS Immunol Med. Microbiol (1998) 21:213–221.
   PubMed Web of Science ®Google Scholar
• JONES SM, GRIFFIN KF, HODGSON I, WILLIAMSON ED: Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine (2003) 21:3912–3918.
   PubMed Web of Science ®Google Scholar
• WILLIAMSON ED, ELEY SM, STAGG AJ et al.: A single dose sub-unit vaccine protects against pneumonic plague. Vaccine (2001) 19:566–571.
   Web of Science ®Google Scholar
• WILLIAMSON ED, ELEY SM, STAGG AJ et al.: A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague. Vaccine (1997) 15:1079–1084.
   PubMed Web of Science ®Google Scholar
• TITBALL RW, WILLIAMSON ED: Second and third generation plague vaccines. Adv. Exp. Med. Biol. (2003) 529:397–406.
   PubMed Web of Science ®Google Scholar
• NAKAJIMA R, MOTIN VL, BRUBAKER RR: Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. (1995) 63:3021–3029.
   PubMed Web of Science ®Google Scholar
• NAKAJIMA R, BRUBAKER RR: Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Inman. (1993) 61:23–31.
   PubMed Web of Science ®Google Scholar
• SING A, ROST D, TVARDOVSKAIA N et al.: Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp. Med. (2002) 196:1017–1024.
   PubMed Web of Science ®Google Scholar
• NEDIALKOV YA, MOTIN VL, BRUBAKER RR: Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect. Inman. (1997) 65:1196–1203.
   PubMed Web of Science ®Google Scholar
• GREEN M, ROGERS D, RUSSELL P et al.: The SCID/Beige mouse as a model to investigate protection against Yersinia pestis FEMS Immunol Med. Microbial. (1999) 23:107–113.
   Web of Science ®Google Scholar
• GROSFELD H, COHEN S, BINO T et al.: Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the Fl capsular antigen. Infect. Inman. (2003) 71(1):374–383.
   PubMed Web of Science ®Google Scholar
• WILLIAMSON ED, BENNETT AM, PERKINS SD et al.: Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague. Vaccine (2002) 20:2933–2941.
   PubMed Web of Science ®Google Scholar
• BENNETT AM, PHILLPOTTS RJ, PERKINS SD, JACOBS SC, WILLIAMSON ED: Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. Vaccine (1999) 18:588–596.
   PubMedGoogle Scholar
• GARMORY HS, LEUSEN D, BROWN KA, TITBALL RW: Protection against plague afforded by immunisation with DNA optimised for expression of the Yersinia pestisV antigen. Vaccine (2004) (In Press).
   Google Scholar
• OYSTON PCF, WILLIAMSON ED, LEARY SEC et al.: Immunization with live recombinant Salmonella typhimurium aroA producing Fl antigen protects against plague. Infect. Immun. (1995) 63:563–568.
   PubMed Web of Science ®Google Scholar
• BULLIFENT HL, GRIFFIN KF, JONES SM et al.: Antibody responses to Yersiniaptstis Fl -antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters. Vaccine (2000) 18:2668–2676.
   PubMed Web of Science ®Google Scholar
• OSORIO JE, POWELL TD, FRANK RS et al.: Recombinant raccoon pox vaccine protects mice against lethal plague. Vaccine (2003) 21:1232–1238.
   PubMed Web of Science ®Google Scholar
• GARMORY HS, GRIFFIN KF, BROWN KA, TITBALL RW: Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine (2003) 21:3051–3057.
   PubMed Web of Science ®Google Scholar
• LEARY SEC, GRIFFIN KF, GARMORY HS, WILLIAMSON ED, TITBALL RW: Expression of an FIN fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb. Pathog. (1997) 23:167–179.
   PubMed Web of Science ®Google Scholar
• ALPAR HO, EYLES JE, WILLIAMSON ED, SOMAVARAPU S: Intranasal vaccination against plague, tetanus and diphtheria. Adv. Drug Deity. Rev (2001) 51:173–201.
   PubMed Web of Science ®Google Scholar
• EYLES JE, SHARP GJ, WILLIAMSON ED, SPIERS ID, ALPAR HO: Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine (1998) 16:698–707.
   PubMed Web of Science ®Google Scholar
• EYLES JE, WILLIAMSON ED, SPIERS ID et al.: Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. .1 Control. Release (2000) 63:191–200.
   Google Scholar
• SPIERS ID, ALPAR HO, EYLES JE et al: Studies on the co-encapsulation, release and integrity of two subunit antigens: rV and rF1 from Yersinia pestis. J. Pharm. Pharmacol (1999) 51:991–997.
   PubMed Web of Science ®Google Scholar
• SPIERS ID, EYLES JE, BAILLIE LWJ, WILLIAMSON ED, ALPAR HO: Biodegradable microparticles with different release profiles: Effect on the immune response after a single administration via intranasal and intramuscular routes. J Pharm. Pharmacol (2000) 52:1195–1201.
   PubMed Web of Science ®Google Scholar
• PRIOR JL, HITCHEN PG, WILLIAMSON ED et al.: Characterization of the lipopolysaccharide of Yersinia pestis. Microb. Pathog. (2001) 30:49–57.
   PubMed Web of Science ®Google Scholar
• SIMPSON WJ, THOMAS RE, SCHWAN TG: Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Jim. I Trop. Med. Hyg. (1990) 43:389–396.
   PubMed Web of Science ®Google Scholar
• ANDREWS GP, STRACHAN ST, BENNER GE et al.: Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect. Inman. (1999) 67:1533–1537.
   PubMed Web of Science ®Google Scholar
• LEARY SEC, GRIFFIN KF, GALYOV EE et al: Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague. Microb. Pathog. (1999) 26:159–169.
   PubMed Web of Science ®Google Scholar
• NEMETH J, STRALEY SC: Effect of Yersinia pestis YopM on experimental plague. Infect. Immun. (1997) 65:924–930.
   PubMed Web of Science ®Google Scholar
• ANDERSON GWJ, LEARY SEC, WILLIAMSON ED et al.: Recombinant V-antigen protects mice against pneumonic and bubonic plague against Fl capsule positive and negative strains of Y pestis Infect. Inman. (1996) 64:4580–4585.
   PubMed Web of Science ®Google Scholar